AzTrials
AzTrials

Bariatric Surgery CandidateNCT05291741

Use of Very Low Calorie Diet Preoperatively to Bariatric Surgery

A study testing VLCD in people with Bariatric Surgery Candidate and Very Low Calorie Diet, run by Aarhus University Hospital at 1 site in Denmark.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

To investigate use of Very Low Calorie Diet preoperatively to bariatric surgery can optimize weight loss prior to surgery and increase the patients' satisfaction. Read more about this study

Who is it for?
Ages 18 to 65 years
What is being tested?
VLCD
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
85 participants
Where
1 siteDenmark
Study dates
1 Oct 2022to 1 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Eligible for bariatric surgery

Who cannot join

  • -

Trial locations and contacts

1 site in 1 country.

Denmark1 site
  • Steno Diabetes Center Aarhus

    Aarhus

Other trials in Denmark

About this study

To investigate use of Very Low Calorie Diet preoperatively to bariatric surgery can optimize weight loss prior to surgery and increase the patients' satisfaction.

Read the detailed description

In this project the investigators want to develop an effective Very Low Calorie Diet (VLCD) treatment prior to bariatric surgery, which is optimized in relation to the size and speed of the weight loss as well as in terms of satisfaction both for the patients as for the health care professionals. Thus the investigators will randomize 500 patients to either VLCD or standard care prior to bariatric surgery. The investigators aim to optimize preoperative and the operative course for patients, who are offered bariatric surgery.

Being tested
VLCD, Standard care
Medical subject headings
Weight Loss

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • VLCDDietary supplement

    Advice regarding VLCD

  • Standard careDietary supplement

    Standard dietary advice for weight loss before bariatric surgery

Study groups in NCT05291741
Study groupRoleWhat they receive
Very Low Calorie Diet (VLCD)Active comparatorVLCD
Receives: Dietary Supplement: VLCD
Standard carePlacebo comparatorStandard care
Receives: Dietary Supplement: Standard care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Weight loss

    Measured: 8 weeks

Secondary outcomes (5)
  1. Patient quality of life measured using the Short Form-12 (SF-12) questionnaire

    Scores range from 0 to 100, with higher scores indicating better physical and mental health functioning

    Measured: 8 weeks and 1 year

  2. Positive and negative consequences of the two weight loss treatments identified by the surgeon, using a questionnaire developed for the purpose

    In the questionnaire, the surgeon will be asked questions on details on the surgery, including duration of surgery and complicating factors.

    Measured: 30 days after surgery

  3. Use of health care services assessed by a medical chart review

    We will assess the number of health care contacts for each patient.

    Measured: 30 days after surgery

  4. Severity of complications assessed by a medical chart review.

    We will define the severity of the contacts based on whether they are outpatient or inpatient contacts.

    Measured: 30 days after surgery

  5. Presence of eating disorders

    The patients will be asked to complete the Eating Disorder Examination Questionnaire (EDE-Q) to assess whether diorderes eating is present. Scores range from 0 to 6 and a score of 4 and above indicate disordered eating.

    Measured: At baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Mar 2022
  2. Study start1 Oct 2022
  3. Primary completion1 Dec 2024
  4. Study completion1 Dec 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
85 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05291741
Sponsor's protocol ID
1-16-02-436-21
Status last verified
Mar 2025
First submitted
21 Feb 2022
Last updated
5 May 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing VLCD in people with Bariatric Surgery Candidate and Very Low Calorie Diet, run by Aarhus University Hospital at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Weight loss (time frame: 8 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in